Month: November 2019

Top news and what to watch in the markets on Monday, November 25, 2019. …read more […]

(Bloomberg) — Want the lowdown on European markets? In your inbox before the open, every day. Sign up here.Uber Technologies Inc. lost its license in London for the second time in less than three years, putting one of its biggest markets outside of the U.S. at risk after the transport regulator said it failed to address safety concerns.The company’s app has a vulnerability that allowed thousands of unauthorized users to pose as Uber drivers by uploading their photos to licensed accounts, Transport for London said in a statement on Monday. Uber has 21 days to appeal and can continue to …read more […]

Pure Storage, Inc. (NYSE:PSTG) just released its latest quarterly report and things are not looking great. It was a… …read more […]

Charles Schwab Corp said on Monday it would acquire TD Ameritrade Holding Corp in an all-stock deal valued at $26 billion, combining the two largest U.S. discount brokerages. As part of the deal, which is expected to close in the second half of 2020, Ameritrade stockholders will get 1.0837 Schwab shares for every share held. TD Ameritrade CEO Tim Hockey is due to step down in February. …read more […]

Today, we’ll introduce the concept of the P/E ratio for those who are learning about investing. We’ll apply a basic… …read more […]

South Bend, Indiana, Mayor Pete Buttigieg has released one of the most detailed retirement plans so far from a 2020 contender …read more […]

* Ex-trade official sees more technology flight from the U.S. SAN FRANCISCO/WASHINGTON, Nov 25 (Reuters) – A U.S.-based foundation overseeing promising semiconductor technology developed with Pentagon support will soon move to Switzerland after several of the group’s foreign members raised concerns about potential U.S. trade curbs. The nonprofit RISC-V Foundation (pronounced risk-five) wants to ensure that universities, governments and companies outside the United States can help develop its open-source technology, its Chief Executive Calista Redmond said in an interview with Reuters. …read more […]

Malaysia’s sovereign wealth fund Khazanah Nasional Bhd has sold stakes worth 5.66 billion ringgit ($1.36 billion) in seven foreign firms including Alibaba Group Holding Ltd in the first 16 months of the current government, a minister said. Khazanah [KHAZA.UL], which made its first loss in a decade last year, has been under pressure to raise funds for the debt-laden government of Prime Minister Mahathir Mohamad who took office in May last year. The fund has sold an undisclosed portion of its stake in Chinese e-commerce giant Alibaba worth 2.23 billion ringgit. …read more […]

Macy’s, Inc. (NYSE:M) shares fell 8.6% to US$15.43 in the week since its latest quarterly results. Revenues of US$5.2b… …read more […]

(Bloomberg) — Want the lowdown on European markets? In your inbox before the open, every day. Sign up here.London’s transit authority refused to grant Uber Technologies Inc. a new license in the capital, endangering the ride-hailing company’s future operations in the city.While the company has made some progress in addressing Transport for London’s concerns, the regulator is still concerned that unauthorized drivers can manipulate the app to carry passengers, it said in a statement Monday. Uber has 21 days to appeal and can continue to operate while a magistrates’ court considers the decision.TfL is particularly concerned about a vulnerability in …read more […]

Uber was stripped of its London operating licence on Monday for the second time in just over two years as the city’s regulator said the taxi app was not “fit and proper”, having put passenger safety at risk. A change to Uber’s systems allowed unauthorised drivers to upload their photos to other drivers’ accounts, meaning they could pick up passengers as if they were the booked driver, which happened in at least 14,000 trips, Transport for London (TfL) said. “It is unacceptable that Uber has allowed passengers to get into minicabs with drivers who are potentially unlicensed and …read more […]

Roche expects its risdiplam medicine for spinal muscular atrophy (SMA) to get U.S. approval by May, the Swiss drugmaker said on Monday, as it takes on Novartis and Biogen in the lucrative rare disease area. The U.S. Food and Drug Administration granted priority review for risdiplam, an oral medicine for those with the potentially deadly muscle-wasting disorder. Roche, whose drug is seen as a rival for Biogen’s Spinraza and Novartis’s Zolgensma gene therapy, said the FDA is due to decide by May 24. …read more […]